Company: CMND
Filing Date: 2025-12-05
Form Type: 6-K
Source: 0001213900-25-118712
Chunk: 2

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: 6-K
Chunk 2
---
, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated
by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance
or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and
uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities
and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report on
Form 20-F for the fiscal year ended October 31, 2024 and subsequent filings with the SEC. Forward-looking statements speak only
as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results,
subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to
the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should
be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements.

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

| Date: December 5, 2025 | Clearmind Medicine, Inc. 
 (Registrant)             
 By:                      | /s/ Adi Zuloff-Shani    |
|:-----------------------|:-------------------------|:------------------------|
|                        | Name:                    | Adi Zuloff-Shani        |
|                        | Title:                   | Chief Executive Officer |

<div align='center'>2</div>